CSE:FFNT

4Front Ventures Refiles Q2 and Annual MD&A and Q2 Financial Statements

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") provides an update today that further to the review by the Ontario Securities Commission (the "OSC") of the Company's continuous disclosure and a subsequent request from OSC staff in connection therewith, the Company has made corrective disclosure with respect to the following documents:

  • management's discussion & analysis for the years ended December 31, 2019 and 2018;
  • management's discussion & analysis for the three and six months ended June 30, 2020 and 2019; and
  • condensed consolidated interim financial statements for the three and six months ended June 30, 2020 and 2019 (reviewed and unaudited).

In  accordance  with OSC Staff Notice 51-711 (Revised) Refilings and Corrections of Errors, (" Notice 51-711 ") the Company has refiled the documents noted above on SEDAR for purposes of making the corrective disclosure described below.

The Company has amended the refiled documents noted above to further break down information with respect to its operating segments and gross profit margins, amend and enhance disclosure relating to real estate income and expenses, removed references to "Systemwide Pro Forma Revenue" and removed the statement that the purchase price allocation for the deemed acquisition of Cannex Capital Holdings Inc. was preliminary and subject to adjustment. The adjustments were made per the OSC's request to ensure more rigid alignment with IFRS reporting requirements. The reorientation of the financial statements as amended will not result in any material change to the Company's financial statements.

As a result of the filing of this disclosure the Company will be placed on the public list of Refiling and Errors in accordance with Notice 51-711.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost, quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear , Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.

Headquartered in Phoenix, Arizona , 4Front has operations in Illinois , Massachusetts , California , Michigan and Washington state . From plant genetics to the cannabis retail experience, 4Front's team applies expertise across the entire cannabis value chain.

SOURCE 4Front Ventures Corp.

Cision View original content: https://www.newswire.ca/en/releases/archive/November2020/17/c2881.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
4Front Ventures

4Front Ventures

Designed for longterm success across the United States.

Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News